Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling.


Journal

Molecular oncology
ISSN: 1878-0261
Titre abrégé: Mol Oncol
Pays: United States
ID NLM: 101308230

Informations de publication

Date de publication:
05 2019
Historique:
received: 16 05 2018
revised: 27 11 2018
accepted: 10 01 2019
pubmed: 29 1 2019
medline: 23 4 2020
entrez: 29 1 2019
Statut: ppublish

Résumé

Perineural invasion (PNI) is a common and characteristic feature of pancreatic ductal adenocarcinoma (PDAC) that is associated with poor prognosis, tumor recurrence, and generation of pain. However, the molecular alterations in cancer cells and nerves within PNI have not previously been comprehensively analyzed. Here, we describe our proteomic analysis of the molecular changes underlying neuro-epithelial interactions in PNI using liquid chromatography-mass spectrometry (LC-MS/MS) in microdissected PNI and non-PNI cancer, as well as in invaded and noninvaded nerves from formalin-fixed, paraffin-embedded PDAC tissues. In addition, an in vitro model of PNI was developed using a co-culture system comprising PDAC cell lines and PC12 cells as the neuronal element. The overall proteomic profiles of PNI and non-PNI cancer appeared largely similar. In contrast, upon invasion by cancer cells, nerves demonstrated widespread plasticity with a pattern consistent with neuronal injury. The up-regulation of SCG2 (secretogranin II) and neurosecretory protein VGF (nonacronymic) in invaded nerves in PDAC tissues was further validated using immunohistochemistry. The tested PDAC cell lines were found to be able to induce neuronal plasticity in PC12 cells in our in vitro established co-culture model. Changes in expression levels of VGF, as well as of two additional proteins previously reported to be overexpressed in PNI, Nestin and Neuromodulin (GAP43), closely recapitulated our proteomic findings in PDAC tissues. Furthermore, induction of VGF, while not necessary for PC12 survival, mediated neurite extension induced by PDAC cell lines. In summary, here we report the proteomic alterations underlying PNI in PDAC and confirm that PDAC cells are able to induce neuronal plasticity. In addition, we describe a novel, simple, and easily adaptable co-culture model for in vitro study of neuro-epithelial interactions.

Identifiants

pubmed: 30690892
doi: 10.1002/1878-0261.12463
pmc: PMC6487729
doi:

Substances chimiques

Neoplasm Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1075-1091

Informations de copyright

© 2019 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.

Références

Pain. 2009 May;143(1-2):114-22
pubmed: 19307059
Front Neuroendocrinol. 2000 Jul;21(3):199-219
pubmed: 10882540
J Neurosci. 2009 Oct 21;29(42):13377-88
pubmed: 19846725
Genes Nutr. 2007 Nov;2(2):169-80
pubmed: 18850173
Cancer Res. 2007 Sep 15;67(18):8633-42
pubmed: 17875703
J Cell Biol. 1985 Nov;101(5 Pt 1):1999-2011
pubmed: 4055903
J Gastrointestin Liver Dis. 2011 Dec;20(4):389-96
pubmed: 22187705
Am J Surg. 2013 Jun;205(6):623-30
pubmed: 23036602
PLoS One. 2010 Dec 09;5(12):e15307
pubmed: 21151573
Gastroenterology. 1994 Jul;107(1):219-30
pubmed: 8020665
Cancer. 1993 Oct 1;72(7):2118-23
pubmed: 8104092
Nat Rev Cancer. 2011 Sep 23;11(10):695-707
pubmed: 21941281
J Clin Endocrinol Metab. 2007 Jul;92(7):2811-5
pubmed: 17440014
Cancer. 2009 Aug 1;115(15):3379-91
pubmed: 19484787
Gastroenterology. 2009 Jan;136(1):177-186.e1
pubmed: 18992743
World J Gastroenterol. 2014 Jul 21;20(27):9154-61
pubmed: 25083089
Proc Natl Acad Sci U S A. 1976 Jul;73(7):2424-8
pubmed: 1065897
Clin Cancer Res. 2009 Apr 15;15(8):2864-71
pubmed: 19351749
Gen Comp Endocrinol. 2007 Jun-Jul;152(2-3):231-41
pubmed: 17559849
Mol Cell Biol. 2000 Oct;20(19):7378-87
pubmed: 10982854
Cancer Discov. 2018 Nov;8(11):1458-1473
pubmed: 30185628
J Neurosci. 2003 Nov 26;23(34):10800-8
pubmed: 14645472
J Neurosci. 1991 Aug;11(8):2552-63
pubmed: 1714494
J Neuroendocrinol. 2017 Mar;29(3):
pubmed: 28166374
Prostate. 2008 Aug 1;68(11):1152-64
pubmed: 18459106
Surgery. 1997 Jul;122(1):53-9
pubmed: 9225915
Asian Pac J Cancer Prev. 2013;14(9):5133-9
pubmed: 24175789
JOP. 2002 Mar;3(2):26-33
pubmed: 11884764
Pancreas. 2018 Aug;47(7):856-863
pubmed: 29975347
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Hum Pathol. 2007 Feb;38(2):299-307
pubmed: 17097719
J Chem Neuroanat. 2011 Dec;42(4):249-61
pubmed: 21621608
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3078-83
pubmed: 26929329
Hepatobiliary Pancreat Dis Int. 2002 Aug;1(3):469-76
pubmed: 14607730
Pancreas. 2004 Aug;29(2):e51-8
pubmed: 15257115
BMC Neurosci. 2002 Oct 25;3:16
pubmed: 12401135
Am J Gastroenterol. 2009 Oct;104(10):2555-65
pubmed: 19568227
J Clin Invest. 2008 Jan;118(1):133-48
pubmed: 18079966
Tohoku J Exp Med. 2007 Jul;212(3):319-34
pubmed: 17592219
Endocrinology. 2005 Dec;146(12):5151-63
pubmed: 16141392
Biochim Biophys Acta. 2011 Dec;1816(2):105-18
pubmed: 21616127
Cytokine Growth Factor Rev. 2010 Feb;21(1):77-82
pubmed: 20060768
Neuroscience. 2010 Oct 27;170(3):942-53
pubmed: 20673789
Cell Mol Neurobiol. 2004 Aug;24(4):517-33
pubmed: 15233376
Cancers (Basel). 2010 Jul 14;2(3):1513-27
pubmed: 24281170
Cancer Res. 2015 May 1;75(9):1777-81
pubmed: 25795709
Hum Pathol. 2009 Feb;40(2):189-98
pubmed: 18799194
Front Endocrinol (Lausanne). 2015 Feb 02;6:3
pubmed: 25699015
J Neurochem. 2003 Nov;87(3):560-73
pubmed: 14535940
Nat Rev Gastroenterol Hepatol. 2015 Nov;12(11):649-59
pubmed: 26460352
Cancer Res. 2014 Mar 15;74(6):1718-27
pubmed: 24448244
Mol Pain. 2008 Dec 10;4:62
pubmed: 19077191
Nat Rev Cancer. 2016 Jun;16(6):399-408
pubmed: 27150016
Mol Cancer Ther. 2009 Jun;8(6):1494-504
pubmed: 19509238
J Neurosci. 2015 Nov 4;35(44):14872-84
pubmed: 26538656
Cancer Cell. 2018 Jan 8;33(1):75-90.e7
pubmed: 29249692
Front Physiol. 2012 Apr 17;3:97
pubmed: 22529816
J Vis Exp. 2018 Apr 23;(134):
pubmed: 29733315
Pancreas. 2011 Apr;40(3):464-8
pubmed: 21289526
J Neurochem. 2008 Jan;104(2):534-44
pubmed: 18173805
Pancreas. 2003 May;26(4):322-5
pubmed: 12717262
Clin Cancer Res. 2006 Apr 15;12(8):2419-26
pubmed: 16638847
Ann Surg. 2010 May;251(5):923-31
pubmed: 20395845

Auteurs

Wasfi Alrawashdeh (W)

Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, UK.

Richard Jones (R)

MS Bioworks, LLC, Ann Arbor, MI, USA.

Laurent Dumartin (L)

Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, UK.

Tomasz P Radon (TP)

Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, UK.

Pedro R Cutillas (PR)

Centre for Haemato-Oncology, Bart Cancer Institute, Queen Mary University of London, UK.

Roger M Feakins (RM)

Department of Histopathology, Royal London Hospital, UK.

Branko Dmitrovic (B)

Department of Pathology and Forensic Medicine, Faculty of Medicine, University of Osijek, Croatia.

Ihsan Ekin Demir (IE)

Department of Surgery, Klinikum rechts der Isar Technische Universität, Munich, Germany.

Guralp O Ceyhan (GO)

Department of Surgery, Klinikum rechts der Isar Technische Universität, Munich, Germany.

Tatjana Crnogorac-Jurcevic (T)

Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH